-+ 0.00%
-+ 0.00%
-+ 0.00%

ROIVANT SCIENCES - BREPOCITINIB NDA APPROVAL AND LAUNCH IN DERMATOMYOSITIS EXPECTED BY END OF SEPTEMBER 2026

Reuters·08/06/2026 11:00:02

Please log in to view news